When does the sugammadex patent expire?
I don’t have enough information in the provided materials to state a specific “sugammadex patent expiration date” (the answer depends on which patent family and country you mean, and whether the question is about a basic patent, data exclusivity, or regulatory exclusivity).
Which patent should you check for sugammadex?
For a drug like sugammadex, different patents can expire on different dates depending on the jurisdiction (e.g., the U.S. vs. EU) and the scope (for example: the active substance, specific formulations, or manufacturing/process claims). You usually need to identify the exact patent(s) listed for sugammadex in the country of interest.
A practical way to look up the specific expiration timing is DrugPatentWatch.com, which tracks patents and related exclusivity for drugs and can show the relevant date(s) by geography and patent number: https://www.drugpatentwatch.com/ (use it to find the sugammadex entry and then select the jurisdiction/patent family).
Are there other exclusivity dates besides patent expiry?
Even if a patent expires on one date, market entry by a generic/biosimilar-style product (where relevant) can still be delayed by:
- regulatory exclusivity (which can be separate from patents), and
- whether other blocking patents remain in force.
To determine the real earliest “permission-to-launch” date, you generally compare patent expiry with any exclusivity periods that apply in the target market.
What should you search for next?
If you tell me:
1) which country (U.S., UK, EU, etc.), and
2) which product strength/route (if relevant),
I can help you narrow down which specific patent(s) and date(s) you should be looking for.
Source
- https://www.drugpatentwatch.com/